Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $16 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein lowered the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $16.00 (from $48.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
